Key facts
- Notable investors include NFX, Spacecadet Ventures, Impatient Ventures, IKJ Capital.
- Status: Privately Held (no backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Permanence Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Permanence Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Permanence Bio
Operator of a biotech research firm intended to find components to fight cancer. The company platform performs research on genome instability and preservation that causes cancer, providing medical organizations with helpful data to counter cancer.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Website
- permanence.bio/
- Ownership
- Privately Held (no backing)
Permanence Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Permanence Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Permanence Bio in its N-PORT filings yet. We sweep new filings monthly.